Episode Details
Back to EpisodesOcular Releases Phase 3 Data for Wet AMD Candidate Axpaxli
Published 3 months, 2 weeks ago
Description
Ocular Therapeutix releases its long-awaited SOL-1 phase 3 data for wet AMD drug candidate Axpaxli; Nordic Pharma expands the availability of its novel dry eye therapy Lacrifill; and Alcon launches the only multifocal toric contact lens featuring Water Gradient Technology.
Learn more about your ad choices. Visit megaphone.fm/adchoices